Starpharma Holdings (ASX:SPL) Interest Paid : A$-0.14 Mil (TTM As of Dec. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Starpharma Holdings Interest Paid?

Starpharma Holdings's Interest Paid for the six months ended in Dec. 2024 was A$-0.07 Mil.

Starpharma Holdings's Interest Paid for the trailing twelve months (TTM) ended in Dec. 2024 was A$-0.14 Mil.

Starpharma Holdings Interest Paid Historical Data

The historical data trend for Starpharma Holdings's Interest Paid can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Starpharma Holdings Interest Paid Chart

Starpharma Holdings Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Interest Paid

Get a 7-Day Free Trial

-0.08

-0.06

-0.05

-0.28

-0.22

Starpharma Holdings Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Interest Paid	Get a 7-Day Free Trial															-0.12	-0.15	-0.16	-0.06	-0.07

Starpharma Holdings Interest Paid Calculation

A company's cash flow from operations for a time period can be determined using either the direct or indirect method. The indirect method modifies the operating section from accrual accounting to a cash basis by taking the net income generated in a period and adding or subtracting changes in the asset and liability accounts to determine the implied cash flow. However, the direct method uses actual cash inflows and outflows from the company's operations directly. Interest Paid represents interest paid on loans, debt or borrowings, in the direct cash flow method.

Interest Paid for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-0.14 Mil.

Starpharma Holdings Interest Paid Related Terms

Thank you for viewing the detailed overview of Starpharma Holdings's Interest Paid provided by GuruFocus.com. Please click on the following links to see related term pages.

Starpharma Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Starpharma Holdings Ltd (ASX:SPL) » Definitions » Interest Paid

Comparable Companies

Traded in Other Exchanges

SPHRY:USA SPHRF:USA PQ6:Germany

Address

4-6 Southampton Crescent, Abbotsford, Melbourne, VIC, AUS, 3067

Website

https://www.starpharma.com

Starpharma Holdings Ltd is an Australia-based company engaged in the research, development, and commercialization of dendrimer products for pharmaceutical, life science, and other applications. It focuses on the development of VivaGel for the management and prevention of bacterial vaginosis and as a condom coating and VIRALEZE an antiviral nasal spray.

Starpharma Holdings Headlines

No Headlines